Literature DB >> 20655626

Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones.

Ahmed S Aboraia1, Bart Makowski, Alba Bahja, David Prosser, Andrea Brancale, Glenville Jones, Claire Simons.   

Abstract

A series of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones were prepared, using an efficient synthetic scheme, and evaluated for their inhibitory activity against cytochrome P450C24A1 (CYP24A1) hydroxylase. In general the reduced benzyl tetralones were more active than the parent benzylidene tetralones. The 2-ethyl and 2-trifluoromethyl benzyl tetralone derivatives (4c and 4b) showed optimal activity in this series with IC(50) values of 1.92 microM and 2.08 microM, respectively compared with the standard ketoconazole IC(50) 0.52 microM. The 2-bromobenzyl tetralone (4d) showed a preference for CYP27A1 (IC(50) 59 nM) over CYP24A1 (IC50 16.3 microM) and may be a useful lead in CYP27A1 inhibition studies. The 2-ethylphenyl benzyl derivative (9c), which showed weak activity against the wild type CYP24A1 (IC(50) 25.57 microM), exhibited enhanced inhibitory activity towards L148F and M416T mutants, this difference in activity for the L148F mutant has been explained using molecular modelling. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655626     DOI: 10.1016/j.ejmech.2010.07.001

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Synthesis of benzyl substituted naphthalenes from benzylidene tetralones.

Authors:  Lorraine M Deck; Quintino Mgani; Andrea Martinez; Alice Martinic; Lisa J Whalen; David L Vander Jagt; Robert E Royer
Journal:  Tetrahedron Lett       Date:  2012-01-25       Impact factor: 2.415

3.  CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma.

Authors:  Guoan Chen; So Hee Kim; Amanda N King; Lili Zhao; Robert U Simpson; Paul J Christensen; Zhuwen Wang; Dafydd G Thomas; Thomas J Giordano; Lin Lin; Dean E Brenner; David G Beer; Nithya Ramnath
Journal:  Clin Cancer Res       Date:  2010-12-17       Impact factor: 12.531

4.  CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.

Authors:  János P Kósa; Péter Horváth; János Wölfling; Dóra Kovács; Bernadett Balla; Péter Mátyus; Evelin Horváth; Gábor Speer; István Takács; Zsolt Nagy; Henrik Horváth; Péter Lakatos
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

5.  Determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors.

Authors:  Rune Tønnesen; Peter Hambak Hovind; Lars Thorbjørn Jensen; Peter Schwarz
Journal:  BMC Public Health       Date:  2016-05-11       Impact factor: 3.295

6.  Vitamin D status among adolescents in Kuwait: a cross-sectional study.

Authors:  Abdullah Al-Taiar; Abdur Rahman; Reem Al-Sabah; Lemia Shaban; Anwar Al-Harbi
Journal:  BMJ Open       Date:  2018-08-01       Impact factor: 2.692

7.  Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach.

Authors:  Kanupriya Mahajan; Himanshu Verma; Shalki Choudhary; Baddipadige Raju; Om Silakari
Journal:  Mol Divers       Date:  2021-07-16       Impact factor: 2.943

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.